Journal Article

Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients

  • Allen N
  • Martin A
  • Snaidr V
  • et al.
New England Journal of Medicine (2023) 388(9) 804-812
DOI: 10.1056/nejmoa2203086
91Citations
Citations of this article
106Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Abstract Background Immunosuppressed organ-transplant recipients have an increased incidence of, and mortality from, skin cancer. Nicotinamide (vitamin B3) enhances the repair of ultraviolet (UV) r...

Cite

CITATION STYLE

APA

Allen, N. C., Martin, A. J., Snaidr, V. A., Eggins, R., Chong, A. H., Fernandéz-Peñas, P., … Damian, D. L. (2023). Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients. New England Journal of Medicine, 388(9), 804–812. https://doi.org/10.1056/nejmoa2203086

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free